Thai shops push to cut FDA vetting role

<p>BANGKOK: Thai advertising agencies are up in arms over what they </p><p>claim is an apparent abuse of power by the Food and Drug Administration </p><p>(FDA) in approving advertisements. </p><p><BR><BR> </p><p>The Advertising Association of Thailand (AAT) has petitioned Public </p><p>Health Minister Sudarat Keyuraphan to look into the role of the FDA and </p><p>has called for a meeting later this month. </p><p><BR><BR> </p><p>The current law hands the FDA the power to examine the claims made in </p><p>advertisements for food and drugs and to check that they are not </p><p>misleading. </p><p><BR><BR> </p><p>However, the AAT argues that the FDA has been exceeding its level of </p><p>authority and expertise by screening products for content deemed </p><p>unsuitable to public morals or culture. </p><p><BR><BR> </p><p>The upshot for Thai advertising agencies has been costly delays and a </p><p>stifling of creativity due to ads getting knocked back and the approval </p><p>process having to start from the beginning. </p><p><BR><BR> </p><p>According to agencies, the screening process can take three weeks. AAT </p><p>president, Parames Rachjaibun, said: "It takes too much time to approve </p><p>and reject advertisements, and FDA judgements have become personal and </p><p>are not professional. </p><p><BR><BR> </p><p>"They have crossed the boundary of what they should do, which is check </p><p>for the benefit of the claim made in the advertisement of the </p><p>product. </p><p><BR><BR> </p><p>"Whether the ad is too sexy, too violent or is not good for society - </p><p>that is not their role. They are not qualified to do this." </p><p><BR><BR> </p><p>The Consumer Protection Board and the Censorship Board are currently </p><p>empowered to check advertisements for dubious content. </p><p><BR><BR> </p><p>The surge in complaints by AAT members and a new Government in power has </p><p>provided a growing push for change in the FDA's vetting power. </p><p><BR><BR> </p><p>"Now there is a new Government, which is trying to support business </p><p>people, there is an opportunity for us to be heard," said Parames. "We </p><p>need to limit the responsibility and role of the FDA. It is time for a </p><p>change." </p><p><BR><BR> </p>

BANGKOK: Thai advertising agencies are up in arms over what they

claim is an apparent abuse of power by the Food and Drug Administration

(FDA) in approving advertisements.



The Advertising Association of Thailand (AAT) has petitioned Public

Health Minister Sudarat Keyuraphan to look into the role of the FDA and

has called for a meeting later this month.



The current law hands the FDA the power to examine the claims made in

advertisements for food and drugs and to check that they are not

misleading.



However, the AAT argues that the FDA has been exceeding its level of

authority and expertise by screening products for content deemed

unsuitable to public morals or culture.



The upshot for Thai advertising agencies has been costly delays and a

stifling of creativity due to ads getting knocked back and the approval

process having to start from the beginning.



According to agencies, the screening process can take three weeks. AAT

president, Parames Rachjaibun, said: "It takes too much time to approve

and reject advertisements, and FDA judgements have become personal and

are not professional.



"They have crossed the boundary of what they should do, which is check

for the benefit of the claim made in the advertisement of the

product.



"Whether the ad is too sexy, too violent or is not good for society -

that is not their role. They are not qualified to do this."



The Consumer Protection Board and the Censorship Board are currently

empowered to check advertisements for dubious content.



The surge in complaints by AAT members and a new Government in power has

provided a growing push for change in the FDA's vetting power.



"Now there is a new Government, which is trying to support business

people, there is an opportunity for us to be heard," said Parames. "We

need to limit the responsibility and role of the FDA. It is time for a

change."